Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00043368
Status:
COMPLETED
Last Update Posted:
2009-03-12
First Post:
2002-08-08
Brief Title:
PF-3512676 CPG 7909 Injection For Patients Who Completed An Oncology Study Using PF-3512676 CPG 7909
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Continuation Study Of PF-3512676 CPG 7909 Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This protocol allows patients who completed Coley oncology studies using PF-3512676 CPG 7909 Injection to continue receiving the treatment until disease progression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CO16 A8501015 | None | None | None |